The EFPIA Code on the Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations
received its formal approval at the general assembly on 24-25 June 2013; it is required to be transposed into national Codes by 31 December 2013.
There are 3 levels of disclosure established: Aggregate, Individual HCO and Individual HCP:
- At an aggregate level : everything concerning clinical trials (phase 1 to 4) for donations and grants, sponsorships, events & hospitality and fees for services & consultancy.
- For individual HCO : Donations & Grants, Sponsorships, events & hospitality: registration fees; travel & accommodation; and associated ToV (Threshold of Visibility. Such as food, beverage & others exceeding threshold), Fees for service & consultancy
- For individual HCP : Same as HCO except fees for service and consultancy
The first disclosure will be made in 2016 for payments of 2015.
Pingback: EFPIA : European Sunshine Act for Pharmaceutica...